Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review-Reference-Cited by-同舟云学术

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review

Published:2024-05 Issue:3 Volume:23 Page:554-560
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Testa Ilaria^ORCID,Indolfi Giuseppe,Brugha Rossa^ORCID,Verkade Henkjan J^ORCID,Terlizzi Vito^ORCID

Funder

Great Ormond Street Hospital Charity

Publisher

Elsevier BV

Reference36 articles.

1. The future of cystic fibrosis care: a global perspective;Bell;Lancet Respir Med,2020

2. The clinical and functional TRanslation of CFTR (CFTR2); available at http://cftr2.org. Date last updated: April 7, 2023. Date last accessed: 31 August 2023.

3. Elexacaftor-tezacaftor-ivacaftor: a life-changing triple combination of CFTR modulator drugs for cystic fibrosis;Bacalhau;Pharmaceuticals (Basel),2023

4. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;Lancet,2019

5. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele;Middleton;N Engl J Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor;The Journal of Pediatrics;2024-11

2. Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant;Current Opinion in Pulmonary Medicine;2024-08-01